http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008022422-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11fa954f88374d0177a18d0fa49b0c01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ad71aab0f80c5eb412da886f91f463a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2007-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_751751d834da4107bf560a027a764c9b |
| publicationDate | 2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2008022422-A1 |
| titleOfInvention | Pharmaceutical compositions for the treatment of tripanossomiasis and chagas disease |
| abstract | The present invention is related to the treatment of tripanossomiasis aiming at the cure of individuals, that suffer from chronic disease, infected for Trypanosomatidae family protozoa. More specifically, the invention deals with established pharmaceutical compositions in the substance association having antiparasitic activity with inhibiting substances of signalling pathways that make possible the Integration of kDNA of T.cruzi in the host genome. A first concretization of the present invention refers to pharmaceutical compositions comprising: (i) at least a substance with antiparasitic activity and (II) a pharmacologically efficient quantity of, at least, one inhibitor of metabolic pathways with performance in the T.cruzi kDNA integration impediment in the host genome. A second concretization of the present invention refers to pharmaceutical compositions comprising: (i) at least a substance with antiparasitic activity and (II) a pharmacologically efficient quantity of, at least, one Inhibitor of metabolic pathways with performance in the Trypanosomatidae family protozoa kDNA integration impediment in the host genome. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9918989-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015006753-A3 |
| priorityDate | 2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.